Participation in National Diabetes Prevention Program Is Cost-Saving

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 7, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 7, 2025 -- Participants with prediabetes enrolled in the National Diabetes Prevention Program (NDPP) have a reduction in direct medical costs over two years, according to a study published online Nov. 20 in Diabetes Care.

Shihchen Kuo, from the University of Michigan in Ann Arbor, and colleagues evaluated the real-world cost-effectiveness of the NDPP. The analysis included individual-level health insurance claims and survey data for 5,948 adults with prediabetes who enrolled (575 individuals) or did not enroll (5,373 individuals) in the NDPP.

The researchers found that compared with nonenrollees, each NDPP enrollee had an average reduction of $4,552 in two-year total direct medical costs. Hospitalizations, outpatient visits, and emergency room visits drove cost savings. There were no significant differences between the groups for EuroQol 5-Dimension 5-level questionnaire utility scores or quality-adjusted life-years (QALYs) gained over two years. Enrollment in the NDPP had an 88 percent probability of saving money and 84 percent probability of being cost-effective at a willingness-to-pay threshold of $100,000/QALY gained over two years.

"If delivered to a larger prediabetes population with longer-term follow-up, the NDPP could potentially reduce health care costs and improve QALYs for millions of American adults with prediabetes," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-08 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords